
Developer of Innovative Drug R&D Platform
Recently, BioMap has been reporting frequent successes, being recognized by Synced, Jiazi Light Year,36Selected by major authoritative media such as Kr and Quantum BitAIField ofTOPCompany, fromScience AI, commercialization capabilities, and other different dimensions. These lists reflect the industry recognition of BioMap as a leading company in large foundational models in life sciences, and also demonstrateAI for ScienceAn increasingly industry-attended trend.
·「AI China」Synced2024Annual Selection
BioMap Selected for Its Innovative Strength and Commercial Prospects"TOP 10 Leading Enterprises in ScienceAI"Synced is a leading media outlet in the field of artificial intelligence. As one of the annual awards that maintains a leading position in the industry in terms of authority, innovation, and influence, "AI"China" Machine Heart Annual Selection2017Since its establishment in [Year], it has been successfully held7The session has received extensive attention and importance from the artificial intelligence community both in China and internationally, to some extent reflecting the weathervane of artificial intelligence technology and industrial development.

· Jiazi Guangnian "Jiazi20」2024The Most Commercially Promising List in the Technology Industry
Jiazi Year Selection "Jiazi20" aims to recognize2024Outstanding technology companies that possess core technical capabilities in various sub-fields of the technology industry and have achieved remarkable success in commercialization. BioMap has been selected.“2024ChinaAI"List of the Most Commercially Promising in the Large Model Field"。

· 36KryptonWISE2024King of Commerce Annual Enterprise
36Krypton AI·WISE2024King of Commerce: The Most Valuable Company of the YearWISE2024The King of Commerce aims to recognize enterprises that have excelled and demonstrated significant commercial potential and influence in the past year. The selection is typically based on a comprehensive evaluation of multiple dimensions, including the enterprise's innovation capability, growth rate, market impact, profitability, and leading position within the industry. BioMap has been successfully selected.“WISE2024King of Commerce YearThe Most Commercially Valuable Enterprise of the Year”。

· Quantum Bit2024AI Annual Awards
Quantum Bit2024Annual Leading AI Enterprises Awards Ceremony in ChinaAIEnterprises that excel in technological innovation, market expansion, and industry influence within the field. These enterprises lead the development in areas such as large models, intelligent computing, and bio-intelligence, driving industrial upgrading and generating widespread social and economic impact. The selection aims to encourage outstanding enterprises at the forefront of technological transformation. BioMap has been successfully selected."Qubit"2024"AI Enterprise of the Year"。

2024In the year, BioMap released a new version of the foundational large model for life sciences.xTrimo V3, continue in2100Hundreds of millions of parameters, full modality coverage (covering proteins,DNA、RNAetc.7In dimensions such as large life sciences and mainstream modalities, BioMap continues to lead globally. The honors from these rankings recognize BioMap's innovation, product strength, and growth potential, while also serving as an encouragement and motivation for us to reach new heights in the coming year.
AboutBioMapBioMap
BioMapBioMap is a pioneer in the global life sciences foundational large model, through2100A billion-parameter cross-modal biological language model decodes the underlying rules of genomes, proteins, cells, and biological systems, building high-quality life sciences with less data and cost consumption.AITask Model. Currently,BioMapAchieved in the fields of drug research and development, biomanufacturing, and healthcare.200More than 10 task modelsState-of-the-Art(SOTA) performance, serving globally800More than 10,000 users have achieved20Billion-dollar total customer orders, helping users inAINovel Protein Design,AITarget Discovery,AIGroundbreaking achievements have been made in the field of enzyme design. The company was founded by Robin Li, the founder of Baidu, and the former Baidu Ventures.CEOLiu Wei co-founded, and by the former Novo Nordisk Global Vice President, formerSAPA core team composed of global vice presidents and other senior industry executives has established research and development centers in Silicon Valley, Beijing, Suzhou, and Hong Kong, and has obtained more than2Billion-dollar venture capital.